CBIO logo

CBIO
Crescent Biopharma Inc.

6,088
Mkt Cap
$597.71M
Volume
544,143.00
52W High
$28.77
52W Low
$8.72
PE Ratio
-1.60
CBIO Fundamentals
Price
$24.57
Prev Close
$21.69
Open
$21.53
50D MA
$13.91
Beta
0.59
Avg. Volume
204,778.93
EPS (Annual)
-$14.78
P/B
3.40
Rev/Employee
$246,454.55
$84.04
Loading...
Loading...
News
all
press releases
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Analysts
Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have earned an average recommendation of "Buy" from the nine research firms that are presently covering the firm, MarketBeat...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened
Crescent Biopharma (NASDAQ:CBIO) Stock Price Passes Above 200 Day Moving Average - What's Next...
MarketBeat·13d ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Shares Pass Above 200-Day Moving Average - Time to Sell?
Crescent Biopharma (NASDAQ:CBIO) Share Price Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat·21d ago
News Placeholder
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of "Buy" from Brokerages
Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) has earned a consensus rating of "Buy" from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have issued a buy rating and three h...
MarketBeat·29d ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded Crescent Biopharma from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·2mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Price Target Lowered to $22.00 at HC Wainwright
HC Wainwright decreased their price target on shares of Crescent Biopharma from $25.00 to $22.00 and set a "buy" rating for the company in a research note on Monday...
MarketBeat·2mo ago
News Placeholder
Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have been assigned a consensus recommendation of "Buy" from the nine ratings firms that are covering the company, Marketbeat.com...
MarketBeat·2mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving Average - Here's What Happened
Crescent Biopharma (NASDAQ:CBIO) Stock Price Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat·2mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen downgraded shares of Crescent Biopharma from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·3mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Upgraded by Guggenheim to Strong-Buy Rating
Guggenheim upgraded Crescent Biopharma to a "strong-buy" rating and set a $35.00 price objective for the company in a research note on Wednesday...
MarketBeat·3mo ago
<
1
2
...
>

Latest CBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.